Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Shalini Garg
IBS (Irritable Bowel Syndrome)
Delhi
This story is a powerful testament to resilience and hope. It narrates the journey of Shalini Gar…
Gaurav Kumar
Chronic Calcific Pancreatitis
Delhi
For over a decade, Gaurav Kumar was trapped in a relentless cycle of agony and hospitalization, b…
Avichal Dixit
Chronic Calcific Pancreatitis
Pilibhit, Uttar Pradesh
This narrative traces the rapid systemic degradation faced by Avichal Dixit, a talented young stu…
Ravinder Kumar
Recurrent Acute Pancreatitis, Diabetes
Panipat, Haryana
This story is a powerful testament to resilience and hope. It narrates the journey of Ravinder Ku…
Rohit Gupta
Chronic Pancreatitis
New Delhi
This is the story of Rohit Gupta , whose resilience transformed a seemingly insurmountable clinic…
Vivaan Guleria
Acute on Chronic Pancreatitis
Dharamshala, Himachal Pradesh
This story is a powerful testament to resilience and hope. It narrates the journey of Vivaan Gule…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis
The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.
Response to Ayurvedic therapy in the treatment of migraine without aura
A study on 204 migraine patients using an Ayurvedic Treatment Protocol (AyTP) showed 35.2% had complete relief, 35.2% had mild episodes without medication, and 70.5% experienced reduced pain frequency and intensity. The preliminary results suggest the AyTP may be effective, though the study's design limits firm conclusions.
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up
A 47-year-old diabetic male with high-risk AML-M3 relapsed after multiple chemotherapy treatments. In 1997, he opted for a pilot Ayurvedic study and was treated with Navajeevan, Kamadudha Rasa, and Keharuba Pisti. He achieved complete remission and has remained disease-free for 13 years without side effects from the alternative treatment.
Significant Reduction of Carbohydrate 19-9 Antigen Levels in a Patient of Acute on Chronic Pancreatitis through Ayurvedic Treatment Protocol
A 52-year-old male with recurrent acute necrotizing pancreatitis showed poor response to conventional treatment, leading to weight loss and high CA 19-9 levels. Ayurvedic therapy, including herbal formulations, a balanced diet, and rest, normalized his CA 19-9 levels within 108 days, highlighting its potential for further study.
Immunomodulatory Effects of a Herbo-Mineral Ayurvedic Formulation in Experimental Models
IMMBO, a herbo-mineral Ayurvedic formulation, shows promise as an immune-modulator in immunosuppressed rats. It enhances immunity, blocks histamine release, and modulates key molecules like TNF-α and NF-κB, offering potential for allergic and immune-related disorders.
Changing Demography of Pancreatitis Patients in India -A Hospital Based Study
Pancreatitis is rising globally, with major risk factors including alcohol, tobacco, and family history. A study of 800 patients in North India found higher incidences among non-alcoholic, non-tobacco users, and those with no family history. The disease mostly affected men (4.6:1) aged 19-45, particularly in the service class and students. Further research is needed to explore its causes and extent in the region.